Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today reported financial results for the second quarter ended June 30, 2009, and provided a corporate
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
SAN DIEGO, CA, August 4, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries,...
Brookstone Pharmaceuticals Appoints New Corporate Position
ALPHARETTA, Ga., July 30 /PRNewswire/ -- Brookstone Pharmaceuticals, LLC, a specialty pharmaceutical company, recently announced the appointment of Philip Vogt as Executive Vice President, Sales and Marketing.
Vogt brings more than thirty years of pharmaceutical experience and wi...
OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development
REDWOOD CITY, Calif., July 7 /PRNewswire/ -- OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel antibody therapeutics that target cancer stem cells, today announced the appointment of Sunil Patel to the position of Senior Vice President, Corporate
Development. In this new po...
Angiotech's corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
VANCOUVER, May 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today announced that its corporate
partner, Boston Scientific Corporation (NYSE: BSX ) has launched the platinum chromium TAXUS(R) Element(TM) Paclitaxel-Eluting Coronary Stent System in select...
Cord Blood America to Hold Conference Call on Thursday May 21st at 11 a.m. Eastern Time to Discuss 2009 First Quarter Results and Corporate Developments
SANTA MONICA, Calif., May 19 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and intern...
Orexigen(R) Therapeutics Announces Jay Hagan as Senior Vice President, Corporate Development and Strategy
SAN DIEGO, May 11 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced that Jay Hagan has joined the organization as Senior Vice President of Corporate
Development and Strategy.
DFB Pharmaceuticals Appoints Maxwell Lea to Vice President Business Development and Corporate Finance
FORT WORTH, Texas, April 23 /PRNewswire/ -- DFB Pharmaceuticals, Inc., has announced the promotion of Maxwell A. Lea, III, to Vice President Business Development and Corporate
Finance. Mr. Lea was most recently Director of Corporate
Development and Finance for the company.
"Since joining DFB...
Alexza's Corporate Presentation to be Webcast at the Future Leaders in the Biotech Industry Conference
MOUNTAIN VIEW, Calif., March 23 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that its corporate
presentation will be webcast live during the 16th Anniversary Future Leaders in the Biotech Industry Conference on Thursday, April 2, 2009 at 3:00 p.m. Easter...
Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference
Company estimates sales of pixantrone, if approved, could potentially reach $1 billion by 2014
SEATTLE, March 19 /PRNewswire-FirstCall/ -- Craig Philips, President of Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) reviewed CTI's programs in a presentation at the 8th Annual WBBA Invest N...
Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update
- Conference Call Today at 4:30 p.m. Eastern Time -
SAN FRANCISCO, March 16 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today reported on its corporate
progress and financial results for the fourth quarter and year ended December 31, 2008.
"We had a very productive ...
Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2008 Financial Results and Corporate Update on March 12, 2009
SAN DIEGO, March 5 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, today announced that it will release its f...
Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech
KANSAS CITY, Mo., Feb. 24 /PRNewswire/ -- An investor group in Trinity
Biotech plc (Nasdaq: TRIB ), an Irish based developer and manufacturer of
diagnostic products, has petitioned the Office of the Director of Corporate
Enforcement to facilitate compliance with key company law provisions de...
Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
MALVERN, Pa. and SHANGHAI, Feb. 23 /PRNewswire/ -- Frontage Laboratories Inc. ("Frontage"), a leading high quality provider of bioanalytical, pre-clinical, clinical and drug development services to global pharmaceutical companies, is pleased to announce it has expanded its research and development...
BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
BIRMINGHAM, Ala., Feb. 6 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced financial results for the fourth quarter and year ended December 31, 2008.
Fourth Quarter 2008 Financial Results
For the three months ended December 31, 2008, the Compan...
Alexza's Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference
MOUNTAIN VIEW, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Alexza
Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that company President
and CEO Thomas B. King will present during the 11th Annual BIO CEO & Investor
Conference on Tuesday, February 10, 2009 at 2:45 p.m. ET. The present...
Vasogen Announces Sale of Patent Application and Provides Corporate Update
MISSISSAUGA, ON, Feb. 2 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ; TSX:VAS) today announced that it has sold a United States patent application and its related foreign counterparts for US$400,000. This device-based intellectual property has not been used to date in the Celacade System;...
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
SAN FRANCISCO, Jan. 13 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA
and Ottawa, Canada) a clinical-stage biotherapeutics company, is pleased to
announce that Samantha Miller has been appointed to the position of Vice
President of Corporate
Ms. Miller has over 15 years ...
Vasogen Provides Corporate Update
MISSISSAUGA, ON, Jan. 6 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ; TSX:VAS) today provided an update on corporate
activities. Pursuant to a previously announced restructuring plan, Vasogen has been reviewing strategic alternatives for the purpose of enhancing shareholder value. This pr...
Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
SAN DIEGO, Jan. 6 /PRNewswire/ -- Accumetrics, Inc. has appointed Andrew Chisholm to the position of Vice President, Sales and Corporate
"Andrew brings the right mix of energy and expertise to Accumetrics. His experience will help us reach the next level in terms of our market pene...
SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE
SAN DIEGO, CA, Dec. 17, 2008 /PRNewswire-FirstCall/ -- Senomyx, Inc.
(Nasdaq: SNMX ), a leading company focused on using proprietary taste receptor
technologies to discover and develop novel flavor ingredients for the food,
beverage, and ingredient supply industries, announced today that Kent Sn...
Nephros Provides Corporate Update
NEW YORK, Nov. 20 /PRNewswire-FirstCall/ -- Nephros, Inc. (Amex: NEP ), a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today provided an update on its operations and strategy.
Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
SAN DIEGO, Nov. 11 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals
Corporation (TSX: NVN) today announced financial results for the third
quarter and nine months ended September 30, 2008, and highlighted several
recent product developments and corporate
Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
- Conference Call Today at 4:30 p.m. Eastern Time -
SAN FRANCISCO, Nov. 10 /PRNewswire-FirstCall/ -- Medivation, Inc.
(Nasdaq: MDVN ) today reported on its corporate
progress and financial
results for the quarter ended September 30, 2008.
"The third quarter represented another qua...
Oncothyreon announces November 6th webcast of third quarter 2008 financial results and corporate update conference call
SEATTLE, Nov. 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq:
ONTY) (TSX:ONY), a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer, today
announced that it intends to release its third quarter financial results on
Genesis Pharmaceuticals Launches New Corporate Website
LAIYANG, China, Nov. 3 /Xinhua-PRNewswire-FirstCall/ -- Genesis
Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ("Genesis" or
the "Company"), a U.S. pharmaceutical company with its principal operations
in the People's Republic of China, today announced the launch of its new
BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update
BIRMINGHAM, Ala., Oct. 31 /PRNewswire-FirstCall/ -- BioCryst
Pharmaceuticals, Inc. (Nasdaq: BCRX ) today announced financial results for
the quarter ended September 30, 2008.
Third Quarter 2008 Financial Results
For the three months ended September 30, 2008, the Company reported
OTC Financial Network Issues Corporate Profile on ProtoKinetix Inc.
VANCOUVER, British Columbia, Oct. 28 /PRNewswire-FirstCall/ --
ProtoKinetix Inc. (OTC Bulletin Board: PKTX), a biotech company focused on
the research, development and commercialization of patented anti-aging
glycopeptides (AAGPs(TM)), announced today that OTC Financial Network
(OTCFN), a divi...
PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
BOSTON, Oct. 23 /PRNewswire-FirstCall/ -- PAREXEL International
Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services
provider, today announced that Alberto Grignolo, Ph.D., Corporate
President, PAREXEL Consulting, has received a Lifetime Achievement Award
from the Goo...
Medivation Receives Corporate Achievement Award From Huntington's Disease Society of America
SAN FRANCISCO, Oct. 16 /PRNewswire-FirstCall/ -- Medivation, Inc.
(Nasdaq: MDVN ) today announced that it will receive a Corporate
Award from the Huntington's Disease Society of America (HDSA), which honors
those companies that exemplify leadership in the fight against Huntington'...
Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
Company Announces Corporate
Restructuring to Focus on Strategic Alliances and M&A
SAN DIEGO, Oct. 8 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals
Corporation (TSX: NVN), a company developing innovative therapeutics for
the treatment of viral infections and c...
Pressure BioSciences, Inc. Provides Corporate Update
SOUTH EASTON, Mass., Oct. 8 /PRNewswire-FirstCall/ -- Pressure
BioSciences, Inc. (Nasdaq: PBIO ) ("PBI") today provided an update on
activities, including the presentation of favorable data
generated by scientists at Amgen, Inc. on the Company's pressure cycling
BioXcel Forms a Corporate Advisory Board for Its Next Phase of Growth
NEW HAVEN, Conn., Oct. 8 /PRNewswire/ -- BioXcel Corporation today
announced the appointment of three distinguished biopharma executives to
Advisory Board (CAB). R. Christopher Seaton, SVP of Global
Transactions, Bayer Healthcare, Martha Matteo, Ph.D., Past President of
SCIP and ...
ACIST Medical Systems Announces the Opening of Its New Expanded Corporate Headquarters in Eden Prairie, MN
EDEN PRAIRIE, Minn., Oct. 7 /PRNewswire/ -- ACIST Medical Systems,
Inc., today announced the grand opening of its new 75,000 square foot,
Headquarters and manufacturing facility in Eden Prairie,
MN. The First Lady Mary Pawlenty and Eden Prairie Mayor Phil Young will
SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
SAN DIEGO, CA, Oct. 7, 2008 /PRNewswire-FirstCall/ -- Senomyx, Inc.
(Nasdaq: SNMX ), a leading company focused on using proprietary taste
receptor technologies to discover and develop novel flavor ingredients for
the food, beverage, and ingredient supply industries, announced today that
Facet Solutions Establishes Corporate Headquarters and Expands Executive Team
HOPKINTON, Mass., Oct. 1 /PRNewswire/ -- Based on the clinical success
of its facet replacement technology, Facet Solutions, Inc. today announced
that the company has expanded its executive management team and established
headquarters in Hopkinton, MA. "The move to Massachusetts
Advanced Life Sciences to Host Conference Call to Update Investors on Progress of Corporate Initiatives on October 1, 2008
CHICAGO, Sept. 24 /PRNewswire-FirstCall/ -- Advanced Life Sciences
Holdings, Inc. (Nasdaq: ADLS ) will conduct a conference call at 9:00 a.m.
Eastern Time on Wednesday, October 1, 2008 to provide an update on third
quarter milestone progress.
Conference Call Details
The conference call wi...
Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion
NEW YORK, Sept. 19 /PRNewswire/ -- Aerolase, the manufacturer of
medical aesthetic lasers, announced today that it has retained SMH Capital
Inc., a subsidiary of Sanders Morris Harris Group (Nasdaq: SMHG ), as its
financial advisor to explore financing alternatives to fund expansion into
2008 National Ergonomics Conference Schedule Announced, Features Four New Tracks of Programming and Focus on Corporate Sustainability and Productivity; Most Product Debuts in Expo's 14-Year History
NEW YORK, Sept. 17 /PRNewswire/ -- The 14th Annual National Ergonomics
Conference and Exposition (NECE) at Caesars Palace, Las Vegas, Dec. 2-5,
will feature a record number of conference sessions, and mark the debut of
four new tracks of conference programming geared toward workplace design
Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
MADISON, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE )
today announced the appointment of Daniel J. McIntyre, 54, to Vice
Communications. Reporting to Timothy P. Cost, Senior
Vice President, Corporate
Affairs, Mr. McIntyre will be responsible for all